Lokivetmab - a new treatment for canine atopic dermatitis

Provided by

Enquire about this course

About the course

Lokivetmab is a new treatment for reducing the clinical signs of atopic dermatitis in dogs. It is also a new type of medicine (a monoclonal antibody) for the treatment of animals in the UK. This module explains about monoclonal antibodies, summarises what is known about the efficacy and safety of lokivetmab in the treatment of canine atopic dermatitis, and discusses where it might fit in the management of atopic dermatitis. 

Enquire

Start date Location / delivery
No fixed date Online Book now

Related article

Advances in technology and improved internet speeds mean much of the 105 hours of CPD a vet is required by the RCVS to complete over three years is ju